Key takeaway
What This Development Means
Denmark has concluded that TMBPA is an endocrine disruptor for both human health and the environment. A harmonised classification under the CLP Regulation is proposed for 2026, paving the way for potential SVHC identification and future REACH controls.
What does Denmark's evaluation of TMBPA mean for EU industry?
TMBPA is now confirmed as an endocrine disruptor, and Denmark will propose harmonised classification in 2026. This could lead to further regulation, including SVHC listing and authorisation requirements.
Is TMBPA currently restricted under REACH?
No. However, classification as an endocrine disruptor is a precursor to potential restriction or authorisation. Companies using TMBPA should monitor regulatory developments closely.
The Danish Environmental Protection Agency has completed its REACH substance evaluation of 4,4'-isopropylidenedi-2,6-xylol (EC No. 227-033-5, CAS No. 5613-46-7), commonly known as Tetramethyl Bisphenol A (TMBPA), confirming significant endocrine-disrupting properties for both human health and the environment.
Acting as the evaluating Member State Competent Authority (MSCA), Denmark reached its conclusion in July 2025, following assessment of in silico, in vitro, and in vivo data. The evaluation forms part of the 2024 Community Rolling Action Plan (CoRAP) under the EU REACH Regulation (EC) No 1907/2006.
Endocrine Disruption Confirmed; Regulatory Classification Proposed
The evaluation confirmed that TMBPA meets the criteria for classification as an endocrine disruptor in Category 1 for both human health and the environment. Denmark plans to submit a harmonised classification and labelling (C&L) dossier in 2026.
While initial concerns also included reproductive toxicity, the evaluating MSCA determined that current evidence does not justify immediate regulatory action in this area. However, the observed endocrine activity—particularly anti-androgenic and estrogenic effects—triggers the need for harmonised classification under the CLP Regulation.
Once a harmonised classification is adopted, TMBPA may be considered for identification as a substance of very high concern (SVHC), marking the first step towards potential REACH authorisation or restriction.
Industrial Uses And Exposure Profile
TMBPA is used primarily as a monomer in imported polymers and is registered in the EU at an annual volume of 1–10 tonnes. Its wide-dispersive use and potential for both environmental and worker exposure were key factors in its selection for evaluation.
Although the substance currently has no harmonised classification, self-classification by registrants already includes hazards such as skin and eye irritation and aquatic toxicity. The proposed classification for endocrine disruption will significantly increase regulatory obligations for manufacturers, importers, and downstream users.
Implications For Industry And Regulatory Stakeholders
The confirmation of TMBPA’s endocrine-disrupting properties positions it alongside other high-profile bisphenols like BPA and BPB, which have faced escalating regulatory restrictions across Europe. Stakeholders in plastics, coatings, electronics, and polymer manufacturing should prepare for future classification and potential authorisation obligations.
Supply chain actors are advised to assess the presence of TMBPA in formulations and begin planning for substitution or reformulation if regulatory progression continues. Updates to safety data sheets and risk assessments should be anticipated ahead of the 2026 classification proposal.
Related Articles
EU Bisphenols Restriction Proposal Targets PVC, Textiles And Thermal Paper
Germany's planned EU REACH restriction could affect bisphenols in PVC, textiles, thermal paper, leather processing, recycling and second-hand markets.
UK REACH Alignment With EU Rules To Shape Chemicals Compliance
The UK plans to use EU chemicals rules as the starting point for UK REACH, reducing the risk of duplicated assessments and regulatory divergence.
European Parliament Backs Expanded Powers For European Chemicals Agency
The European Parliament’s proposed reforms would substantially expand ECHA’s scientific, regulatory and coordination functions. The changes reinforce transparency, non-animal testing and inter-agency cooperation while increasing regulatory oversight across the EU chemicals sector.
